Last updated on June 2019

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)


Brief description of study

This study will evaluate the efficacy, safety, and tolerability of adjunctive ALKS 5461 in adults who have treatment refractory MDD.

Clinical Study Identifier: NCT03188185

Find a site near you

Start Over

Alkermes Investigational Site

Little Rock, AR United States
  Connect »

Alkermes Investigational Site

Los Alamitos, CA United States
  Connect »

Alkermes Investigational Site

Oceanside, CA United States
  Connect »

Alkermes Investigational Site

Pico Rivera, CA United States
  Connect »

Alkermes Investigational Site

San Diego, CA United States
  Connect »

Alkermes Investigational Site

Santa Ana, CA United States
  Connect »

Alkermes Investigational Site

Sherman Oaks, CA United States
  Connect »

Alkermes Investigational Site

Hollywood, FL United States
  Connect »

Alkermes Investigational Site

Jacksonville, FL United States
  Connect »

Alkermes Investigational Site

Lauderhill, FL United States
  Connect »

Alkermes Investigative Site

Palm Bay, FL United States
  Connect »

Alkermes Investigational Site

Hoffman Estates, IL United States
  Connect »

Alkermes Investigational Site

Pikesville, MD United States
  Connect »

Alkermes Investigational Site

Mount Kisco, NY United States
  Connect »

Alkermes Investigational Site

Cincinnati, OH United States
  Connect »

Alkermes Investigational Site

Oklahoma City, OK United States
  Connect »

Alkermes Investigational Site

Allentown, PA United States
  Connect »

Alkermes Investigational Site

Richardson, TX United States
  Connect »

Alkermes Investigational Site

Woodstock, VT United States
  Connect »

Alkermes Investigative Site

Bellevue, WA United States
  Connect »